In this section
| Condition | Year screening commenced* | Analysis and referral |
| Congential Hypothyroidism (CHT) | 1980s | Newborn Screening Lab |
| Phenylketonuria (PKU) | 1970s | Willink Laboratory |
| Sickle Cell Disease (SCD) | 2004/05 | Newborn Screening Lab |
| Medium-chain acyl-CoA Dehydrogenase Deficiency (MCADD) | 2004 | Willink Laboratory |
| Cystic Fibrosis (CF) | 2007 | Newborn Screening Lab |
| Glutaric aciduria type 1 (GA1) | 2012 | Willink Laboratory |
| Homocystinuria | 2012 | Willink Laboratory |
| Isovaleric acidaemia (IVA) | 2012 | Willink Laboratory |
| Maple syrup urine disease (MSUD) | 2012 | Willink Laboratory |
| SCID (evaluation) | 2021 | Newborn Screening Lab |
| Hereditary Tyrosinaemia Type 1 (HT1) | 2025 | Willink Laboratory |
*The year screening commenced is approximate. In some cases this was part way through a year and initially may have included only certain areas. It is important not to assume that individual babies have been screened for a particular condition. Health professionals should contact their local Child Health Department, in the first instance, for any historical enquiries.
(Last reviewed October 2025)